X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare J.B.Chemicals with Dr. Reddys - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

J.B.CHEMICALS vs DR. REDDYS LAB - Comparison Results

J.B.CHEMICALS    Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

DR. REDDYS LAB 
   Change

Dr. Reddy's is a leading pharmaceutical company in the country with presence across the value chain. While the global generics business accounted for 69% of total revenues in FY12, the PSAI business (Pharma Services and Active Ingredients - PSAI) con... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    J.B.CHEMICALS DR. REDDYS LAB J.B.CHEMICALS/
DR. REDDYS LAB
 
P/E (TTM) x 14.8 29.2 50.6% View Chart
P/BV x 2.3 2.9 81.6% View Chart
Dividend Yield % 0.2 0.9 17.6%  

Financials

 J.B.CHEMICALS   DR. REDDYS LAB
EQUITY SHARE DATA
    J.B.CHEMICALS
Mar-16
DR. REDDYS LAB
Mar-17
J.B.CHEMICALS/
DR. REDDYS LAB
5-Yr Chart
Click to enlarge
High Rs3183,397 9.4%   
Low Rs2002,560 7.8%   
Sales per share (Unadj.) Rs148.0856.5 17.3%  
Earnings per share (Unadj.) Rs19.178.0 24.5%  
Cash flow per share (Unadj.) Rs23.9139.9 17.1%  
Dividends per share (Unadj.) Rs0.5020.00 2.5%  
Dividend yield (eoy) %0.20.7 28.8%  
Book value per share (Unadj.) Rs128.9739.8 17.4%  
Shares outstanding (eoy) m84.82165.74 51.2%   
Bonus/Rights/Conversions -BB-  
Price / Sales ratio x1.73.5 50.3%   
Avg P/E ratio x13.638.2 35.5%  
P/CF ratio (eoy) x10.821.3 50.8%  
Price / Book Value ratio x2.04.0 49.9%  
Dividend payout %2.625.7 10.2%   
Avg Mkt Cap Rs m21,951493,632 4.4%   
No. of employees `0002.722.7 12.1%   
Total wages/salary Rs m1,84131,068 5.9%   
Avg. sales/employee Rs Th4,590.96,259.0 73.3%   
Avg. wages/employee Rs Th673.41,369.8 49.2%   
Avg. net profit/employee Rs Th592.1569.7 103.9%   
INCOME DATA
Net Sales Rs m12,551141,961 8.8%  
Other income Rs m5421,715 31.6%   
Total revenues Rs m13,093143,676 9.1%   
Gross profit Rs m2,05524,722 8.3%  
Depreciation Rs m41210,266 4.0%   
Interest Rs m96634 15.1%   
Profit before tax Rs m2,08815,537 13.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m0349 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m4692,965 15.8%   
Profit after tax Rs m1,61912,921 12.5%  
Gross profit margin %16.417.4 94.0%  
Effective tax rate %22.519.1 117.7%   
Net profit margin %12.99.1 141.7%  
BALANCE SHEET DATA
Current assets Rs m7,77896,837 8.0%   
Current liabilities Rs m4,35884,199 5.2%   
Net working cap to sales %27.28.9 306.0%  
Current ratio x1.81.2 155.2%  
Inventory Days Days5573 74.5%  
Debtors Days Days8098 81.9%  
Net fixed assets Rs m5,713102,552 5.6%   
Share capital Rs m170829 20.5%   
"Free" reserves Rs m10,547121,792 8.7%   
Net worth Rs m10,937122,621 8.9%   
Long term debt Rs m05,449 0.0%   
Total assets Rs m15,574218,165 7.1%  
Interest coverage x22.825.5 89.5%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.80.7 123.9%   
Return on assets %11.06.2 177.2%  
Return on equity %14.810.5 140.5%  
Return on capital %20.012.9 154.8%  
Exports to sales %48.754.6 89.2%   
Imports to sales %7.19.4 75.7%   
Exports (fob) Rs m6,11577,520 7.9%   
Imports (cif) Rs m88913,274 6.7%   
Fx inflow Rs m6,16981,670 7.6%   
Fx outflow Rs m1,28526,355 4.9%   
Net fx Rs m4,88455,315 8.8%   
CASH FLOW
From Operations Rs m1,39721,444 6.5%  
From Investments Rs m-320-18,404 1.7%  
From Financial Activity Rs m-1,196-3,692 32.4%  
Net Cashflow Rs m-102-1,144 8.9%  

Share Holding

Indian Promoters % 55.4 25.5 217.3%  
Foreign collaborators % 0.3 0.0 -  
Indian inst/Mut Fund % 3.4 5.4 62.8%  
FIIs % 3.9 35.3 11.0%  
ADR/GDR % 0.0 18.5 -  
Free float % 37.0 15.3 241.8%  
Shareholders   30,437 75,885 40.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare J.B.CHEMICALS With:   SHASUN PHARMA  CIPLA  TORRENT PHARMA  ALEMBIC LTD  WYETH LTD  

Compare J.B.CHEMICALS With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices End Day Flat; Oil and Gas Stocks Lead Losses(Closing)

After opening the day in red, share markets in India witnessed negative trading activity throughout the day and ended the day on a weak note.

Related Views on News

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

The Foundation for Sensex 100,000 is Laid(The 5 Minute Wrapup)

Feb 17, 2018

Top three reasons for Tanushree's presentation at Equitymaster Conference to be centered around a possible 30% correction.

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

The Markets Want Your Money. Don't Give It to Them.(Smart Contrarian)

Feb 9, 2018

MFs are having a gala time taking money from over-eager investors and funneling it into equities. Smart investors, though, know better than to do that.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

NPAs Set to Rise Further with New RBI Rules(Chart Of The Day)

Feb 15, 2018

The RBI overhauls bad loan framework. Banks may come under additional pressure due to rising NPAs and increased provisioning.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

J.B.CHEMICALS SHARE PRICE


Feb 22, 2018 (Close)

TRACK J.B.CHEMICALS

  • Track your investment in J.B.CHEMICALS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

J.B.CHEMICALS 5-YR ANALYSIS

COMPARE J.B.CHEMICALS WITH

MARKET STATS